Phillip McCarthy

1.5k total citations
15 papers, 693 citations indexed

About

Phillip McCarthy is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Phillip McCarthy has authored 15 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 5 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Phillip McCarthy's work include Hematopoietic Stem Cell Transplantation (7 papers), Multiple Myeloma Research and Treatments (3 papers) and Polyomavirus and related diseases (3 papers). Phillip McCarthy is often cited by papers focused on Hematopoietic Stem Cell Transplantation (7 papers), Multiple Myeloma Research and Treatments (3 papers) and Polyomavirus and related diseases (3 papers). Phillip McCarthy collaborates with scholars based in United States, Canada and Australia. Phillip McCarthy's co-authors include Robert Peter Gale, S.W. Hui, Sergio Giralt, Waleska S. Pérez, Vikas Gupta, M-J Zhang, Steven H. Bernstein, Mustafa Beneklı, M. S. Czuczman and Hillard M. Lazarus and has published in prestigious journals such as Journal of Clinical Oncology, The FASEB Journal and Leukemia.

In The Last Decade

Phillip McCarthy

15 papers receiving 675 citations

Peers

Countries citing papers authored by Phillip McCarthy

Since Specialization

Citations

This map shows the geographic impact of Phillip McCarthy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip McCarthy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip McCarthy more than expected).

Fields of papers citing papers by Phillip McCarthy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip McCarthy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip McCarthy. The network helps show where Phillip McCarthy may publish in the future.

Co-authorship network of co-authors of Phillip McCarthy

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip McCarthy. A scholar is included among the top collaborators of Phillip McCarthy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip McCarthy. Phillip McCarthy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Financial impact of allogeneic hematopoietic cell transplantation on patients and families over 2 years: results from a multicenter pilot study 2016 ·Bone Marrow Transplantation ·Ellen M. Denzen, Viengneesee Thao, Theresa Hahn, S. J. Lee, Phillip McCarthy, J. Douglas Rizzo, (unknown), Rebecca Drexler, Susan Flesch, (unknown), Nancy A. Omondi, Elizabeth Murphy, (unknown), Navneet S. Majhail	30
2	Comparison of non-myeloablative conditioning regimens for lymphoproliferative disorders 2014 ·Bone Marrow Transplantation ·Sanghee Hong, (unknown), Andrew Artz, Phillip McCarthy, Brent R. Logan, Marcelo C. Pasquini	4
3	Second transplants for multiple myeloma relapsing after a previous autotransplant—reduced-intensity allogeneic vs autologous transplantation 2013 ·Bone Marrow Transplantation ·César O. Freytes, David H. Vesole, (unknown), Xiaobo Zhong, Robert Peter Gale, RA Kyle, Donna Reece, J. N. Alastair Gibson, Harry C. Schouten, Phillip McCarthy, Sagar Lonial, A. Krishnan, Angela Dispenzieri, Parameswaran Hari	38
4	Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS 2011 ·Bone Marrow Transplantation ·Selina M. Luger, Olle Ringdén, M-J Zhang, Waleska S. Pérez, Michael R. Bishop, Martin Bornhäuser, Christopher Bredeson, Mitchell S. Cairo, Edward A. Copelan, Robert Peter Gale, Sergio Giralt, Zafer Gülbaş, Vikas Gupta, Gregory A. Hale, Hillard M. Lazarus, Victor Lewis, Michael Lill, Phillip McCarthy, Daniel Weisdorf, Michael A. Pulsipher	194
5	Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis 2011 ·Bone Marrow Transplantation ·H. Jean Khoury, (unknown), J M Goldman, (unknown), Jörg Halter, Mukta Arora, Vikas Gupta, David A. Rizzieri, (unknown), Armand Keating, Gale Rp, D I Marks, Phillip McCarthy, (unknown), Jeff Szer, Sergio Giralt, Richard T. Maziarz, Jörge E. Cortes, Mary M. Horowitz, S. J. Lee	62
6	Relationship of Race/Ethnicity and Survival after Single Umbilical Cord Blood Transplantation for Adults and Children with Leukemia and Myelodysplastic Syndromes 2011 ·Biology of Blood and Marrow Transplantation ·Karen K. Ballen, John P. Klein, Tanya L. Pedersen, Deepika Bhatla, Reggie Duerst, Joanne Kurtzberg, Hillard M. Lazarus, Charles F. LeMaistre, Phillip McCarthy, Paulette Mehta, Jeanne Palmer, Michelle Setterholm, John R. Wingard, Steven Joffe, Susan K. Parsons, Galen E. Switzer, Stephanie J. Lee, J. Douglas Rizzo, Navneet S. Majhail	28
7	Phase III intergroup study of lenalidomide versus placebo maintenance therapy following single autologous stem cell transplant (ASCT) for multiple myeloma (MM): CALGB 100104. 2010 ·Journal of Clinical Oncology ·Phillip McCarthy, Kouros Owzar, K. C. Anderson, Craig C. Hofmeister, Hani Hassoun, David D. Hurd, Edward A. Stadtmauer, S. Giralt, Vera Hárs, Claudia Linker, (unknown)	55
8	Atypical Presentation Of Vaginal GvHD With Abdominal Pain Crises 2010 ·Biology of Blood and Marrow Transplantation ·(unknown), Pamela Paplham, (unknown), Chirag M. Vyas, Phillip McCarthy, (unknown), Karen Brown, (unknown), (unknown), Minoo Battiwalla	1
9	Is the international staging system superior to the Durie–Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant 2009 ·Leukemia ·Parameswaran Hari, M-J Zhang, Vivek Roy, Waleska S. Pérez, Asad Bashey, Luen Bik To, Gerald J. Elfenbein, César O. Freytes, Robert Peter Gale, John Gibson, Robert A. Kyle, H M Lazarus, Phillip McCarthy, Giuseppe Milone, S Pavlovsky, Donna Reece, Gary J. Schiller, Jorge Vela‐Ojeda, Daniel J. Weisdorf, David H. Vesole	74
10	Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation 2007 ·Transplant Infectious Disease ·Minoo Battiwalla, Pamela Paplham, Nikolaos G. Almyroudis, (unknown), (unknown), (unknown), Patricia P. Smith, Joanne Becker, Phillip McCarthy, Brahm H. Segal	57
11	209: Practice variation in supportive care in hematopoietic cell transplantation 2007 ·Biology of Blood and Marrow Transplantation ·(unknown), Mary Eapen, Robert J. Soiffer, Phillip McCarthy, Fausto R. Loberiza, Nancy A. Kernan, Madan Jagasia, (unknown), Andrew Artz, Steven Joffe	1
12	Use of nonvolume-reduced (unmanipulated after thawing) umbilical cord blood stem cells for allogeneic transplantation results in safe engraftment 2003 ·Bone Marrow Transplantation ·Theresa Hahn, Udomsak Bunworasate, (unknown), (unknown), Wichai Chinratanalab, Arif Alam, (unknown), Maria R. Baer, James L. Slack, Meir Wetzler, Joanne Becker, Phillip McCarthy	18
13	High‐efficiency electrotransfection of human primary hematopoietic stem sells 2001 ·The FASEB Journal ·(unknown), Phillip McCarthy, S.W. Hui	47
14	Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis 2000 ·Bone Marrow Transplantation ·Mustafa Beneklı, (unknown), (unknown), Steven H. Bernstein, M. S. Czuczman, Phillip McCarthy	72
15	Psoriasis with oral manifestations. 1977 ·PubMed ·E Cataldo, Phillip McCarthy, Howard S. Yaffee	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact